EU Committee To Discuss Future COVID-19 Vaccine Purchasing Deals
The health commissioner and three member state health ministers will take part in a debate on how advance purchase agreements were drawn up during the pandemic, and how they should be handled in future health crises.
You may also be interested in...
European healthcare leaders debated the usefulness of joint procurement and state aid for the generics and biosimilars companies at a recent Politico panel, in light of rising inflation across the continent.
The new regulation on cross-border threats to health is the final part of the European Health Union, along with strengthened roles for the European Medicines Agency and the European Centre for Disease Prevention and Control. Its aim is to ensure collective EU action on preparedness, surveillance, risk assessment, and early warning and response in the event of health emergencies.
The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.